The post has been translated automatically. Original language: English
Biotechnologies have already entered their super cycle for the next 5 years.
Two key trends are converging now.
Firstly, there has been a powerful cultural shift towards optimizing health, active longevity, and luxmaxing, which has already become mainstream.
Secondly, AI, which on the one hand has already become the No. 1 doctor, and on the other hand radically reduces the time needed to find and develop new drugs.
This was not possible a few years ago, but today the search for molecules is faster, optimization is better, and medical solutions and protocols are personalized.
Early signals can't help but inspire. The story is about an IT specialist from Australia who, with the help of AI, synthesized an anti-cancer drug for his dying dog, the founder of GitLab, who, with the help of AI, solved the problem of his cancer when traditional medicine could no longer offer him anything, and the boom of peptides among enthusiasts optimizing their own health.
This is the process of the sovereignization of health and the decentralization of medicine.
The biohacking supercycle has already begun.
We will help every loyal customer to become our shareholder. We will also invest in breakthrough biotechnological projects at the intersection of biohacking, decentralized and personalized medicine, independent research, and active and functional longevity.
The coming months will be truly breakthrough.
Biotechnologies have already entered their super cycle for the next 5 years.
Two key trends are converging now.
Firstly, there has been a powerful cultural shift towards optimizing health, active longevity, and luxmaxing, which has already become mainstream.
Secondly, AI, which on the one hand has already become the No. 1 doctor, and on the other hand radically reduces the time needed to find and develop new drugs.
This was not possible a few years ago, but today the search for molecules is faster, optimization is better, and medical solutions and protocols are personalized.
Early signals can't help but inspire. The story is about an IT specialist from Australia who, with the help of AI, synthesized an anti-cancer drug for his dying dog, the founder of GitLab, who, with the help of AI, solved the problem of his cancer when traditional medicine could no longer offer him anything, and the boom of peptides among enthusiasts optimizing their own health.
This is the process of the sovereignization of health and the decentralization of medicine.
The biohacking supercycle has already begun.
We will help every loyal customer to become our shareholder. We will also invest in breakthrough biotechnological projects at the intersection of biohacking, decentralized and personalized medicine, independent research, and active and functional longevity.
The coming months will be truly breakthrough.